Objective: This study is to formulate Nebivolol into a Pulsatile liquid, solid composite compression coated tablet, which will delay the release of drug in early morning hypertension conditions. Methods: The tablet was formulated and compressed with ethylcellulose coating polymer. percent vitro liquid tested. Based on disintegration time wetting time, LCS2, LCS3, LSC6, LCS7 LCS12 formulations w...